top of page
Olaris CEO sits on panel, "The Evolving Role of Biomarkers and Diagnostics"
Olaris CEO, Dr. Liz O'Day, sits on a panel at the Cancer Advance Conference to discuss how biomarkers and diagnostics are changing how we treat cancer.
April 24, 2019

bottom of page